Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,980.00
Bid: 11,974.00
Ask: 11,976.00
Change: -46.00 (-0.38%)
Spread: 2.00 (0.017%)
Open: 12,070.00
High: 12,144.00
Low: 11,940.00
Prev. Close: 12,026.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

10 Feb 2022 07:34

UPDATE 4-AstraZeneca sees higher 2022 sales even as COVID boost wanes

* Quarterly results top expectations, dividend raised* Shares among top FTSE 100 gainers* Overall 2022 revenue to rise, but COVID-sales will fall* Vaccine sales drop to be offset by antibody drug (Adds CEO comment on vaccine)By Pushkala Aripaka and ...

Read more
10 Feb 2022 07:34

UPDATE 3-AstraZeneca sees higher 2022 sales, but COVID boost waning

* Quarterly results top expectations, dividend raised* Shares among top FTSE 100 gainers* Overall 2022 revenue to rise, but COVID-sales will fall* Vaccine sales drop to be offset by antibody drug (Adds shares, analyst comment, paragraphs 7,8)By Push...

Read more
10 Feb 2022 07:34

UPDATE 2-AstraZeneca sees higher 2022 sales, but COVID boost waning

* Vaccine sales to drop, antibody drug to rise* Overall sales to rise, but COVID-sales will fall* Quarterly results top expectations (Adds details on COVID-19 products, background)By Pushkala Aripaka and Ludwig BurgerFeb 10 (Reuters) - AstraZeneca f...

Read more
10 Feb 2022 07:34

UPDATE 1-AstraZeneca sees 2022 growth as dividend rises but COVID boost falls

(Adds details on earnings, forecast, background)Feb 10 (Reuters) - AstraZeneca on Thursday forecast higher 2022 sales and raised its annualised dividend after the drugmaker posted better-than-expected fourth-quarter profit as it gets a lift from i...

Read more
10 Feb 2022 07:10

AstraZeneca sees 2022 growth, but COVID boost to drop

Feb 10 (Reuters) - AstraZeneca on Thursday forecast higher 2022 sales after the drugmaker posted better-than-expected fourth-quarter profit as it gets a lift from its COVID-19 antibody treatment.The drugmaker, however, like rival GSK, warned that ...

Read more
10 Feb 2022 07:04

AstraZeneca raises dividend on growth prospects

(Sharecast News) - AstraZeneca announced the first increase to its dividend for a decade and an upbeat outlook as the drugs company swung to a fourth-quarter loss driven by higher costs.

Read more
9 Feb 2022 18:32

Thursday preview: US CPI, AstraZeneca in focus

(Sharecast News) - Investors' attention will be firmly on the latest consumer price due out in the US covering the month of January.

Read more
7 Feb 2022 15:26

Immune system creates neutralising antibodies against Omicron after three exposures

(Sharecast News) - German scientists have shown that the human immune system creates an abundant amount of high quality antibodies capable of neutralising Omicron once it has encountered the virus's spike protein three times.

Read more
7 Feb 2022 14:41

UPDATE 4-U.S. adds Chinese entities to red-flag export list, WuXi Bio shares plunge

(Adds Chinese commerce ministry comment)WASHINGTON, Feb 7 (Reuters) - The U.S. Commerce Department said on Monday it had added 33 Chinese entities to its so-called 'unverified list', which requires U.S. exporters to go through more procedures befo...

Read more
7 Feb 2022 14:41

UPDATE 3-U.S. adds Chinese entities to red-flag export list, WuXi Bio shares plunge

(Adds statement from Hymson)WASHINGTON, Feb 7 (Reuters) - The U.S. Commerce Department said on Monday it had added 33 Chinese entities to its so-called 'unverified list', which requires U.S. exporters to go through more procedures before shipping ...

Read more
3 Feb 2022 16:18

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
3 Feb 2022 11:42

UPDATE 3-Britain gets fifth COVID vaccine after Novavax approval

* Approved for use in 18 year olds and above* Agreement in place for supply of 60 mln doses* Novavax shares turn positive in premarket trading (Adds details from statements)By Pushkala AripakaFeb 3 (Reuters) - Britain on Thursday approved Novavax's ...

Read more
3 Feb 2022 11:42

UPDATE 4-Britain gets fifth COVID vaccine after Novavax approval

* Approved for use in 18 year olds and above* Agreement in place for supply of 60 mln doses* Novavax shares turn positive in premarket trading (Adding details on deliveries)By Pushkala AripakaFeb 3 (Reuters) - Britain on Thursday approved Novavax's ...

Read more
3 Feb 2022 11:42

UPDATE 2-Britain approves Novavax COVID vaccine as fifth in country

* Approved for use in 18 year olds and older* Agreement in place for supply of 60 mln doses* Novavax shares turn positive in premarket trading (Adds Novavax statement, shares, detail, background)By Pushkala AripakaFeb 3 (Reuters) - Britain has appro...

Read more
2 Feb 2022 19:29

COVID SCIENCE-Placenta may have mechanism that protects fetus from COVID; vaccines safe with rheumatic diseases

By Nancy LapidFeb 2 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.Placenta may shed proteins...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.